Silexion Therapeutics (SLXN) Selling, General & Administrative (2023 - 2026)
Silexion Therapeutics' Selling, General & Administrative was $1.47 million in Q2 2026, up 16.0% from $1.27 million a year earlier and up 6.5% from the prior quarter.
Powered by 
Analysis
Silexion Therapeutics (SLXN) Selling, General & Administrative (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Silexion Therapeutics' Selling, General & Administrative was $5.01 million through Jun 30, 2026, down 38.7% year-over-year; for FY2025, it came in at $4.49 million, down 33.5% from FY2024.
- In earlier years, Selling, General & Administrative was $6.76 million in FY2024 (+594.3%) and $973,000 in FY2023.
- The Q2 2026 figure marks the highest quarterly Selling, General & Administrative since Q3 2024.
- Compared with a year earlier, Selling, General & Administrative has increased for three straight quarters, with growth averaging 65.7% over the last seven quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q1 2025 (growth of 266.8%); the worst was Q3 2025 (a decline of 76.4%).
- Per Business Quant data, SLXN's Selling, General & Administrative in the three quarters before Q2 2026 was $1.38 million (Q1 2026), $1.03 million (Q4 2025) and $1.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Silexion Therapeutics | 178,711.77 | -19.70 Mn | - | 1.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.47 Mn |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 4.82 Mn |
| Jun 30, 2024 | 619,000.00 |
| Mar 31, 2024 | 289,000.00 |
| Dec 31, 2023 | 471,000.00 |
| Sep 30, 2023 | 196,000.00 |
| Jun 30, 2023 | 179,000.00 |
API Access
Silexion Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SLXN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "SLXN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SLXN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();